tirzepatide liver side effects Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic disease (MASLD) First Report of Tirzepatide Hepatotoxicity

The failing heart is often described as an engine out of fuel. It struggles to generate enough adenosine triphosphate (ATP) , the bodys energy currency, and its ability to utilize glucose for energy is impaired

This highlights the fact that the development of FD goes beyond just the buildup of sphingolipids and underscores the importance of using additional therapeutic approaches, such as heart failure medication where appropriate alongside ERT

Ania Jastreboff, associate professor at Yale School of Medicine and obesity medicine physician-scientist, tells TODAY.com

Patients were randomized to saxagliptin plus dapagliflozin (5 and 10 mg/day